Allianz Asset Management
MGNX icon

Allianz Asset Management’s MacroGenics MGNX Stock Holding History

Allianz Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-29,302
Closed -$471K – 2559
2021
Q4 		$471K Sell
29,302
-97,650
-77% -$1.84M ﹤0.01% 2225
2021
Q3 		$2.66M Buy
126,952
+20,728
+20% +$499K ﹤0.01% 1544
2021
Q2 		$2.85M Sell
106,224
-11,835
-10% -$347K ﹤0.01% 1346
2021
Q1 		$3.76M Buy
118,059
+22,887
+24% +$556K ﹤0.01% 1172
2020
Q4 		$2.18M Buy
95,172
+32,777
+53% +$755K ﹤0.01% 1293
2020
Q3 		$1.57M Buy
62,395
+36,206
+138% +$989K ﹤0.01% 1324
2020
Q2 		$731K Buy
+26,189
New +$455K ﹤0.01% 1932
2019
Q4 		– Sell
-27,406
Closed -$350K – 2818
2019
Q3 		$350K Sell
27,406
-120,893
-82% -$1.74M ﹤0.01% 2481
2019
Q2 		$2.52M Sell
148,299
-4,830
-3% -$83K ﹤0.01% 1797
2019
Q1 		$2.75M Buy
153,129
+52,139
+52% +$901K ﹤0.01% 1719
2018
Q4 		$1.28M Sell
100,990
-3,521
-3% -$59K ﹤0.01% 1928
2018
Q3 		$2.24M Buy
104,511
+8,824
+9% +$188K ﹤0.01% 1891
2018
Q2 		$1.98M Buy
95,687
+26,743
+39% +$602K ﹤0.01% 1945
2018
Q1 		$1.74M Buy
68,944
+17,010
+33% +$413K ﹤0.01% 1980
2017
Q4 		$987K Sell
51,934
-87
-0.2% -$1.62K ﹤0.01% 2238
2017
Q3 		$961K Buy
52,021
+39
+0.1% +$676 ﹤0.01% 2265
2017
Q2 		$910K Sell
51,982
-967
-2% -$18.4K ﹤0.01% 2251
2017
Q1 		$985K Sell
52,949
-14,388
-21% -$278K ﹤0.01% 2239
2016
Q4 		$1.38M Sell
67,337
-45,341
-40% -$1.14M ﹤0.01% 2105
2016
Q3 		$3.37M Sell
112,678
-11,122
-9% -$331K ﹤0.01% 1779
2016
Q2 		$3.34M Buy
123,800
+74,252
+150% +$1.67M ﹤0.01% 1694
2016
Q1 		$929K Sell
49,548
-1,371
-3% -$26.1K ﹤0.01% 2117
2015
Q4 		$1.58M Sell
50,919
-814
-2% -$24.7K ﹤0.01% 1804
2015
Q3 		$1.11M Buy
51,733
+9,143
+21% +$287K ﹤0.01% 1789
2015
Q2 		$1.62M Buy
42,590
+4,539
+12% +$149K ﹤0.01% 1788
2015
Q1 		$1.19M Sell
38,051
-522
-1% -$17.7K ﹤0.01% 1732
2014
Q4 		$1.35M Buy
+38,573
New +$962K ﹤0.01% 1714

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allianz Asset Management's MGNX Position: Q1 2022 in Review

Allianz Asset Management sold out of MacroGenics (MGNX) in Q1 2022, closing a stake of 29,302 shares — an estimated $471K sold.

Allianz Asset Management first reported a position in MGNX in Q4 2014 and held it in 27 quarters. The position peaked at $3.76M in Q1 2021. 144 funds tracked by Wall St. Rank hold MGNX as of Q1 2022.

  • Allianz Asset Management reported no remaining MacroGenics position as of Q1 2022 after selling out during the quarter.
  • Allianz Asset Management sold 29,302 MacroGenics shares in Q1 2022, an estimated $471K.
  • Allianz Asset Management first reported a position in MacroGenics in Q4 2014 and held it in 27 quarters.
  • Allianz Asset Management's MacroGenics position peaked at $3.76M in Q1 2021.
  • 144 funds tracked by Wall St. Rank held MacroGenics as of Q1 2022.

Based on Allianz Asset Management's 13F filing for Q1 2022, filed 13 May 2022.